CASPASE INHIBITORS, ESPECIALLY CASPASE 3 INHIBITORS, FOR THE TREATMENT OF INFLUENZA

摘要

The invention relates to the use of at least one caspase inhibitor, especially a caspase 3 inhibitor, for producing a pharmaceutical composition for the prophylaxis and/or treatment of a viral infection, especially an infection with an negative-strand RNA virus, preferably an influenza infection. The invention also relates to a test system for identifying suitable active ingredients.